Fortitude Family Office’s Eikon Therapeutics EIKN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58K Buy
+121
New +$1.24K ﹤0.01% 1582

Other funds holding EIKN

Fortitude Family Office's EIKN Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Eikon Therapeutics (EIKN) in Q2 2026: 121 shares worth $1.58K. The stake represents ﹤0.01% of the portfolio and ranks #1582 among its holdings.

5 funds tracked by Wall St. Rank hold EIKN as of Q2 2026.

  • Fortitude Family Office held 121 shares of Eikon Therapeutics worth $1.58K as of Q2 2026.
  • Eikon Therapeutics was a new Fortitude Family Office position in Q2 2026.
  • Eikon Therapeutics made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1582 holding.
  • 5 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.